Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Sonja Vliek; Agnes Jager; Mojca Jonge-Lavrencic; Jean-Pierre Lotz; Anthony Goncalves; Monika Graeser; Ulrike Nitz; Ingrid A. M. Mandjes; Marjo J. Holtkamp; Margaret Schot; Valesca P. Retel; Evelien J. Kuip; Machteld N. Wymenga; Inge R. Konings; Vivianne C. G. Tjan-Heijnen; Judith R. Kroep; Der Carolien P. Schr; Elsken van Der Wall; Sabine C. Linn

Journal articles

Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Sonja Vliek Agnes Jager Mojca Jonge-Lavrencic Jean-Pierre Lotz Anthony Goncalves ^{1, 2} Monika Graeser Ulrike Nitz Ingrid A. M. Mandjes Marjo J. Holtkamp Margaret Schot Valesca P. Retel Evelien J. Kuip Machteld N. Wymenga Inge R. Konings Vivianne C. G. Tjan-Heijnen Judith R. Kroep Der Carolien P. Schr Elsken van Der Wall Sabine C. Linn

1 Institut Paoli-Calmettes

2 CRCM - Centre de Recherche en Cancérologie de Marseille

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-02143680
Contributor : Ghislain Bidaut Connect in order to contact the contributor
Submitted on : Wednesday, May 29, 2019 - 2:53:19 PM
Last modification on : Wednesday, November 3, 2021 - 9:47:44 AM

Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Identifiers

Collections

Citation

Export

Metrics

47

Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Identifiers

Collections

Citation

Export

Share

Metrics

47